Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration

NCT06221787 is registered in ClinicalTrials.gov with Fujian Medical University Union Hospital as lead sponsor.

NCT NCT06221787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06221787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration
Lead sponsor
Fujian Medical University Union Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2022
Completion date
July 1, 2026
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma